Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
Descripción del Articulo
Objective: To describe the characteristics of clinically non-functioning hypothalamic-pituitary tumors (THCNF). Material and methods: Descriptive, cross-sectional, retrospective study of 67 THCNF stories. from patients who attended the author's private practice, collected from January 2 to Marc...
Autor: | |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2024 |
Institución: | Fundación Instituto Hipólito Unanue |
Repositorio: | Diagnóstico |
Lenguaje: | español |
OAI Identifier: | oai:revistadiagnostico.fihu.org.pe:article/515 |
Enlace del recurso: | https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515 |
Nivel de acceso: | acceso abierto |
Materia: | Hipotálamo hipófisis tumores no funcionantes Hypothalamus pituitary gland tumors non-functioning |
id |
REVFIHU_97cf7d021f0968d12cfca6ab64eee7ed |
---|---|
oai_identifier_str |
oai:revistadiagnostico.fihu.org.pe:article/515 |
network_acronym_str |
REVFIHU |
network_name_str |
Diagnóstico |
repository_id_str |
|
dc.title.none.fl_str_mv |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors Diagnóstico, evolución y tratamiento de los tumores hipotálamo-hipofisarios clínicamente no funcionantes |
title |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors |
spellingShingle |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors Garmendia-Lorena, Fausto Hipotálamo hipófisis tumores no funcionantes Hypothalamus pituitary gland tumors non-functioning |
title_short |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors |
title_full |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors |
title_fullStr |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors |
title_full_unstemmed |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors |
title_sort |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors |
dc.creator.none.fl_str_mv |
Garmendia-Lorena, Fausto |
author |
Garmendia-Lorena, Fausto |
author_facet |
Garmendia-Lorena, Fausto |
author_role |
author |
dc.subject.none.fl_str_mv |
Hipotálamo hipófisis tumores no funcionantes Hypothalamus pituitary gland tumors non-functioning |
topic |
Hipotálamo hipófisis tumores no funcionantes Hypothalamus pituitary gland tumors non-functioning |
description |
Objective: To describe the characteristics of clinically non-functioning hypothalamic-pituitary tumors (THCNF). Material and methods: Descriptive, cross-sectional, retrospective study of 67 THCNF stories. from patients who attended the author's private practice, collected from January 2 to March 31, 2023 with manifestations of expansion of the hypothalamus-pituitary region. Information is given on age, weight, height, BMI, blood pressure, concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 53.7% women, 42.2± 15.5 years old, weight 71.1kg, height 1.63m, BMI 26.1, BP 130/75 mmHg, PRL14.9±12.3 ng/ml, STH 1.00 ±1.51 ng/ml, TSH 4.06±3.65 mIU/L, LH 5.69±5.28 IU/L, T4 6.86±2.68 ug/dl, T3 92.0±20.8 ng/dl, F 10.4 ±7.52 ug/dl, T 2.68±3.25 ng/dL, E2 28.3±9.07 pg/ml. TRH test: 6.56-14.8-14.8 mIU/L TSH. GnRH test: 4.0, 6.09, 6.11, 8.32, 6.87 IU/L LH. Insulin hypoglycemia: 0.95, 0.94, 2.24, 1.23, 1.4 ng/ml STH; 6.82, 9.64, 12.3, 11.6, 9.9 ug/dL cortisol. Blood glucose 86.6±7.08, 39.5±11.0, 63.3±10.9, 74.0±12.7, 77.0±12.0. All showed an increase in the sella turcica. Except for 3 who had normal vision, the rest presented altered vision from bitemporal hemianopia to blindness. The majority underwent transsphenoidal hypophysectomy, some received additional radiotherapy. Conclusions: THCNF had normal basal hormonal concentrations and limited responses to stimulatory tests. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-05-24 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515 10.33734/diagnostico.v63i2.515 |
url |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515 |
identifier_str_mv |
10.33734/diagnostico.v63i2.515 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515/492 |
dc.rights.none.fl_str_mv |
Derechos de autor 2024 Fausto Garmendia-Lorena https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2024 Fausto Garmendia-Lorena https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Fundación Instituto Hipólito Unanue |
publisher.none.fl_str_mv |
Fundación Instituto Hipólito Unanue |
dc.source.none.fl_str_mv |
Diagnóstico; Vol. 63 No. 2 (2024); e515 Diagnostico; Vol. 63 Núm. 2 (2024); e515 1018-2888 2709-7951 10.33734/diagnostico.v63i2 reponame:Diagnóstico instname:Fundación Instituto Hipólito Unanue instacron:FIHU |
instname_str |
Fundación Instituto Hipólito Unanue |
instacron_str |
FIHU |
institution |
FIHU |
reponame_str |
Diagnóstico |
collection |
Diagnóstico |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1842087236504387584 |
spelling |
Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumorsDiagnóstico, evolución y tratamiento de los tumores hipotálamo-hipofisarios clínicamente no funcionantesGarmendia-Lorena, FaustoHipotálamohipófisistumoresno funcionantesHypothalamuspituitary glandtumorsnon-functioningObjective: To describe the characteristics of clinically non-functioning hypothalamic-pituitary tumors (THCNF). Material and methods: Descriptive, cross-sectional, retrospective study of 67 THCNF stories. from patients who attended the author's private practice, collected from January 2 to March 31, 2023 with manifestations of expansion of the hypothalamus-pituitary region. Information is given on age, weight, height, BMI, blood pressure, concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 53.7% women, 42.2± 15.5 years old, weight 71.1kg, height 1.63m, BMI 26.1, BP 130/75 mmHg, PRL14.9±12.3 ng/ml, STH 1.00 ±1.51 ng/ml, TSH 4.06±3.65 mIU/L, LH 5.69±5.28 IU/L, T4 6.86±2.68 ug/dl, T3 92.0±20.8 ng/dl, F 10.4 ±7.52 ug/dl, T 2.68±3.25 ng/dL, E2 28.3±9.07 pg/ml. TRH test: 6.56-14.8-14.8 mIU/L TSH. GnRH test: 4.0, 6.09, 6.11, 8.32, 6.87 IU/L LH. Insulin hypoglycemia: 0.95, 0.94, 2.24, 1.23, 1.4 ng/ml STH; 6.82, 9.64, 12.3, 11.6, 9.9 ug/dL cortisol. Blood glucose 86.6±7.08, 39.5±11.0, 63.3±10.9, 74.0±12.7, 77.0±12.0. All showed an increase in the sella turcica. Except for 3 who had normal vision, the rest presented altered vision from bitemporal hemianopia to blindness. The majority underwent transsphenoidal hypophysectomy, some received additional radiotherapy. Conclusions: THCNF had normal basal hormonal concentrations and limited responses to stimulatory tests. Objetivo: Describir las características de los tumores hipotálamo-hipofisarios clinicamente no funcionantes (THCNF). Material y métodos: Estudio descriptivo, transversal, retrospectivo de 67 historias de THCNF de pacientes que asistieron a la práctica privada del autor, recolectadas del 02 de enero al 31 de marzo del año 2023 con manifestaciones de expansión de la región hipotálamo hipofisaria. Se informa sobre la edad, peso, talla, IMC, presión arterial, concentraciones de prolactina (PRL), hormona tirotrófica (TSH), luteotrófica (LH), folículo-estimulante (FSH), somatotropina (STH), tiroxina (T4), triiodo-tironina (T3), cortisol (F), testosterona (T) en varones, estradiol (E2) en mujeres, glucosa (G). Pruebas estimulatorias con TRH, GnRH, hipoglicemia insulínica, radiografías, campimetrías oculares y tratamiento. Resultados: 53,7 % mujeres, 42,2± 15,5 años, peso 71,1kg, talla 1.63m, IMC 26,1, PA 130/75 mmHg, PRL14,9±12,3 ng/ml, STH 1,00±1,51 ng/ml, TSH 4,06±3,65 mUI/L, LH 5,69±5,28 UI/L, T4 6.86±2,68 ug/dl, T3 92,0±20,8 ng/dl , F 10,4 ±7,52 ug/dl, T 2,68±3,25 ng/dL, E2 28,3±9,07 pg/ml. Prueba TRH: 6,56-14,8-14,8 mUI/L de TSH. Prueba GnRH: 4,0, 6,09, 6,11, 8,32, 6,87 UI/L de LH. Hipoglicemia insulínica: 0,95, 0,94, 2,24, 1,23, 1,4 ng/ml de STH; 6,82, 9,64, 12,3, 11,6, 9,9 ug/dL de cortisol. Glicemia 86,6±7,08, 39,5±11,0, 63,3±10,9, 74,0±12,7, 77,0±12,0. Todos mostraron incremento de la silla turca. Excepto 3 que tuvieron visión normal, el resto presentó alteración de la visión desde hemianopsia bitemporal hasta ceguera La mayoría fue sometida a hipofisectomía transesfenoidal, algunos recibieron radioterapia adicional. Conclusiones: Los THCNF tuvieron concentraciones hormonales basales normales y respuestas limitadas a las pruebas estimulatorias.Fundación Instituto Hipólito Unanue2024-05-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/51510.33734/diagnostico.v63i2.515Diagnóstico; Vol. 63 No. 2 (2024); e515Diagnostico; Vol. 63 Núm. 2 (2024); e5151018-28882709-795110.33734/diagnostico.v63i2reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515/492Derechos de autor 2024 Fausto Garmendia-Lorenahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/5152024-08-23T01:20:24Z |
score |
13.10263 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).